Skip to main content

Boise State University Clinical and Translational Research Program

Claire Xiong with assistant in the Materials Science Lab.

Clinical research directly involves people or uses human elements such as behavior or tissue samples. Translational research applies findings from scientific inquiry to clinical and community practice to benefit individuals and the community.

Thus, clinical and translational research takes research from bench to bedside in a way that makes it relevant beyond the lab. The Clinical and Translational Research Program works with three community partners: Saint Alphonsus Regional Medical Center, St. Luke’s Regional Medical Center, and Acutus Medical.

What does the Boise State Clinical and Translational Research Program do?

  • Provides networking opportunities with regional medical professionals and facilities
  • Helps with research concept development
  • Offers mentorship and an experiential pipeline
  • Helps organize grant writing workshops
  • Provides Institute of Translational Health Science (ITHS) and Clinical Translation
  • Research Infrastructure Network (CTR-IN) information

Getting Started

First Step

To get started, check out this information regarding Clinical Translational Research: CTR PowerPoint

Click below to submit a protocol or to have your questions regarding human subjects answered.

Visit Boise State’s Institutional Review Board (IRB) webpage.

Funding Opportunities

Institute of Translational Health Sciences

Washington, Wyoming, Alaska, Montana, and Idaho

View ITHS Opportunities:

Clinical Translational Research  – Infrastructure Network

Alaska, Hawaii, Idaho, Montana, Nevada, New Mexico, Wyoming

View CTR-IN Opportunities:

http://ctrin.unlv.edu/

Contact Us

  • Cheryl Jorcyk

    Cheryl Jorcyk

    Director of Clinical Translational Research

    Meet Director Cheryl Jorcyk

    Dr. Cheryl Jorcyk is director of the Boise State clinical translational research program. She is a professor in both the Department of Biological Sciences and in the Biomolecular Research Ph.D. Program.

    Jorcyk is chair of the Boise State University Biomedical Institutional Review Board for the Protection of Human Subjects committee and a member of the Regional Advisory Workgroup for University of Washington ITHS. She has received clinical/translational research training at the Dana-Farber Cancer Institute in Boston through the American Association for Cancer Research.

    Jorcyk holds a Ph.D. in biology from Johns Hopkins University and her undergraduate degree, also in biology, from Pennsylvania State University. She completed a postdoctoral fellowship at the National Cancer Institute, National Institutes of Health.

    Current Research Focus

    Currently, Jorcyk’s lab focuses on studying the role of the inflammatory factor Oncostatin M (OSM) in breast cancer invasion and metastasis, and translational studies to develop a novel therapeutic to block OSM are underway. She first began studying OSM and its function in tumor progression through collaboration with the Boise VA Medical Center.

    Meet Director Cheryl Jorcyk

    Dr. Cheryl Jorcyk is director of the Boise State clinical translational research program. She is a professor in both the Department of Biological Sciences and in the Biomolecular Research Ph.D. Program.

    Jorcyk is chair of the Boise State University Biomedical Institutional Review Board for the Protection of Human Subjects committee and a member of the Regional Advisory Workgroup for University of Washington ITHS. She has received clinical/translational research training at the Dana-Farber Cancer Institute in Boston through the American Association for Cancer Research.

    Jorcyk holds a Ph.D. in biology from Johns Hopkins University and her undergraduate degree, also in biology, from Pennsylvania State University. She completed a postdoctoral fellowship at the National Cancer Institute, National Institutes of Health.

    Current Research Focus

    Currently, Jorcyk’s lab focuses on studying the role of the inflammatory factor Oncostatin M (OSM) in breast cancer invasion and metastasis, and translational studies to develop a novel therapeutic to block OSM are underway. She first began studying OSM and its function in tumor progression through collaboration with the Boise VA Medical Center.

Community Contacts

Community contacts for Clinical and Translational Research at Boise State University include:

Saint Alphonsus Regional Medical Center

Ronnie McMurren
(208) 367-8897
Ronnie.McMurren@saintalphonsus.org

Nichole Whitener MSN, CNRN, NE-BC
Director Neuroscience Services
Research Administrator
Office:(208) 367-2233
Cell: (208) 870-4478
Fax:(208) 367-6821
nichole.whitener@saintalphonsus.org

View Saint Alphonsus Institutional Review Board

St. Luke’s Regional Medical Center

General Information (St. Luke’s Regulatory Office): (208) 381-8926

Hilary Flint-Wagner, Ph.D., M.P.H.
Applied Research Manager
St. Luke’s Research
(208) 381-8934
flintwah@slhs.org

Visit St. Luke’s Information for Researchers Website

Acutus Medical

Calvin Allan
Manager of Advanced Technology Development
Calvin.allan@acutus.com